Farms.com Home   News

Cattle Producers Urge Ottawa to Terminate UK Trade Deal

The Canadian Cattle Association (CCA) is calling on Ottawa to end the Canada–UK Continuity Agreement, arguing that the United Kingdom has failed to honour its commitments and continues to block Canadian beef exports. 

The call follows the introduction earlier this week of legislation to implement the U.K.’s accession to the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP). The CCA contends that, despite repeated warnings and years of discussion, the UK has not acted to remove non-tariff barriers that prevent Canadian beef from entering its market. 

“We’re calling on all parliamentarians to stand up for Canadian beef producers,” CCA President Tyler Fulton said in a release Thursday. “In these uncertain geopolitical times, we need every opportunity to diversify our markets.” 

Since 2023, UK beef exports to Canada have surged from $16.6 million to $42.5 million in 2024 — a 156% increase — while Canadian beef exports to the UK have dropped to zero in both 2024 and 2025. From January to August 2025 alone, UK beef imports totalled $32.2 million, up 19% from the same period in 2024. 

The CCA argues that the UK’s ongoing refusal to accept Canada’s meat inspection and production standards violates international trade rules. Specifically, the UK continues to apply the European Union’s hormone-treated beef ban — despite a 1997 World Trade Organization (WTO) ruling against it — and refuses to grant full systems approval to Canada’s “world-class” meat hygiene system. 

The Continuity Agreement, enacted in April 2021 after Brexit, was meant to serve as a bridge until a permanent bilateral deal could be reached within three years. However, the UK withdrew from negotiations.  

CCA leaders say terminating the continuity deal would allow both sides to restart talks on fair, rules-based trade that benefits farmers and consumers alike.  

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.